DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

DexCom (NASDAQ:DXCM – Free Report) had its price objective boosted by Wells Fargo & Company from $90.00 to $94.00 in a report ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

9 July 2024 Pan-European court hands down second infringement decision | Revokes patent Europe-wide after counterclaim | ...

The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...

Continuous Glucose Monitoring Devices Market was valued at US$ 5.89 Bn in 2024 and is to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9%.

The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...

In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...

Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors ...

Glucose Sensor Market. The global glucose sensor market is projected to witness substantial growth, reaching a valuation of ...

Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) ...

DUBLIN-- ( BUSINESS WIRE )--The "Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Blood Glucose Monitoring Devices ...